Cargando…

Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir

Mutations continue to accumulate within the SARS-CoV-2 genome, and the ongoing epidemic has shown no signs of ending. It is critical to predict problematic mutations that may arise in clinical environments and assess their properties in advance to quickly implement countermeasures against future var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torii, Shiho, Kim, Kwang Su, Koseki, Jun, Suzuki, Rigel, Iwanami, Shoya, Fujita, Yasuhisa, Jeong, Yong Dam, Ito, Jumpei, Asakura, Hiroyuki, Nagashima, Mami, Sadamasu, Kenji, Yoshimura, Kazuhisa, Sato, Kei, Matsuura, Yoshiharu, Shimamura, Teppei, Iwami, Shingo, Fukuhara, Takasuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089321/ https://www.ncbi.nlm.nih.gov/pubmed/36972312 http://dx.doi.org/10.1371/journal.ppat.1011231

Ejemplares similares

Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction
por: Torii, Shiho, et al.
Publicado: (2021)

Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication
por: Nakajima, Shogo, et al.
Publicado: (2023)

Role of miR-122 and lipid metabolism in HCV infection
por: Fukuhara, Takasuke, et al.
Publicado: (2012)

Secretory glycoprotein NS1 plays a crucial role in the particle formation of flaviviruses
por: Tamura, Tomokazu, et al.
Publicado: (2022)

Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication
por: Tsuji, Genichiro, et al.
Publicado: (2022)

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
por: Suzuki, Rigel, et al.
Publicado: (2022)

Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection
por: Kim, Kwang Su, et al.
Publicado: (2021)

Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study
por: Ejima, Keisuke, et al.
Publicado: (2022)

A highly pathogenic simian/human immunodeficiency virus effectively produces infectious virions compared with a less pathogenic virus in cell culture
por: Iwanami, Shoya, et al.
Publicado: (2017)

Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors
por: Tatematsu, Daiki, et al.
Publicado: (2023)

Designing isolation guidelines for COVID-19 patients utilizing rapid antigen tests: a simulation study using viral dynamics models
por: Jeong, Yong Dam, et al.
Publicado: (2022)

Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model
por: Ejima, Keisuke, et al.
Publicado: (2021)

Cautious handling of urine from moderate to severe COVID-19 patients
por: Nomoto, Hidetoshi, et al.
Publicado: (2020)

Designing isolation guidelines for COVID-19 patients with rapid antigen tests
por: Jeong, Yong Dam, et al.
Publicado: (2022)

Revisiting the guidelines for ending isolation for COVID-19 patients
por: Jeong, Yong Dam, et al.
Publicado: (2021)

Estimation of the incubation period of COVID-19 using viral load data
por: Ejima, Keisuke, et al.
Publicado: (2021)

Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
por: Ito, Jumpei, et al.
Publicado: (2023)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
por: Kim, Kwang Su, et al.
Publicado: (2021)

Bayesian statistical method for detecting structural and topological diversity in polymorphic proteins
por: Hayashi, Shuto, et al.
Publicado: (2022)

Correction: SARS-CoV-2 suppression depending on the pH of graphene oxide nanosheets
por: Islam, Md. Saidul, et al.
Publicado: (2023)

SARS-CoV-2 suppression depending on the pH of graphene oxide nanosheets
por: Islam, Md. Saidul, et al.
Publicado: (2023)

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
por: Saito, Akatsuki, et al.
Publicado: (2021)

Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
por: Kimura, Izumi, et al.
Publicado: (2022)

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
por: Tamura, Tomokazu, et al.
Publicado: (2023)

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
por: Saito, Akatsuki, et al.
Publicado: (2022)

Intracellular delivery of serum-derived hepatitis C virus
por: Fukuhara, Takasuke, et al.
Publicado: (2011)

Development of a High-Throughput Serum Neutralization Test Using Recombinant Pestiviruses Possessing a Small Reporter Tag
por: Tetsuo, Madoka, et al.
Publicado: (2020)

Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection
por: Kumata, Ryuichi, et al.
Publicado: (2022)

CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
por: Suda, Takahiro, et al.
Publicado: (2018)

Performance evaluation of Novaplex SARS-CoV-2 variants assay kit series for SARS-CoV-2 detection using single nucleotide polymorphisms
por: Ogihara, Shinji, et al.
Publicado: (2022)

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
por: Yamasoba, Daichi, et al.
Publicado: (2022)

Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma
por: Iwanami, Shoya, et al.
Publicado: (2020)

Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy
por: Inokuchi, Shoichi, et al.
Publicado: (2021)

Topological data analysis of protein structure and inter/intra-molecular interaction changes attributable to amino acid mutations
por: Koseki, Jun, et al.
Publicado: (2023)

SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
por: Motozono, Chihiro, et al.
Publicado: (2021)

Establishment of a Cell Culture Model Permissive for Infection by Hepatitis B and C Viruses
por: Otoguro, Teruhime, et al.
Publicado: (2020)

Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study
por: Iwanami, Shoya, et al.
Publicado: (2021)

A novel occludin-targeting monoclonal antibody prevents hepatitis C virus infection in vitro
por: Okai, Ken, et al.
Publicado: (2018)

M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening
por: Yamada, Hiroshi, et al.
Publicado: (2021)

Remdesivir
por: Bakheit, Ahmed H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gbrf3vovb26pqlpsij02s155sr